Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aggressive vs nonaggressive therapy for metastatic NSCLC

N Thatcher1, R M Niven, H Anderson

  • 1Department of Medical Oncology, Christie Hospital NHS Trust, Withington, Manchester, UK.

Chest
|May 1, 1996
PubMed
Summary

Clinicians often underestimate chemotherapy benefits for metastatic non-small cell lung cancer, while patients are more accepting. Balancing quality of life and symptom relief is crucial for treatment assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

General practice workforce retention strategies: an umbrella review.

BMC primary care·2026
Same author

Properties of Heavy Cosmic Nuclei Phosphorus, Chlorine, Argon, Potassium, and Calcium: Results from the Alpha Magnetic Spectrometer.

Physical review letters·2026
Same author

Reducing Anaesthesia's Carbon Footprint: A Survey of Awareness and Attitudes.

Irish medical journal·2026
Same author

Antiprotons and Elementary Particles over a Solar Cycle: Results from the Alpha Magnetic Spectrometer.

Physical review letters·2025
Same author

Solar Modulation of Cosmic Nuclei over a Solar Cycle: Results from the Alpha Magnetic Spectrometer.

Physical review letters·2025
Same author

Properties of Cosmic Deuterons Measured by the Alpha Magnetic Spectrometer.

Physical review letters·2024

Area of Science:

  • Oncology
  • Clinical Medicine
  • Patient-Reported Outcomes

Background:

  • Clinicians frequently underestimate the modest benefits of chemotherapy.
  • Reluctance to refer for chemotherapy may stem from perceived side effects outweighing benefits.

Purpose of the Study:

  • To explore the discrepancy between clinician and patient acceptance of chemotherapy.
  • To highlight the importance of quality of life and symptom relief in treatment assessment for metastatic non-small cell lung cancer.

Main Methods:

  • Qualitative assessment of clinician and patient perspectives on chemotherapy.
  • Review of treatment assessment parameters beyond survival.

Main Results:

  • Patients are more willing to accept chemotherapy, even with small expected benefits.

Related Experiment Videos

  • Clinicians tend to underestimate potential benefits, focusing on side effects.

    • Conclusions:

    • Quality of life, performance status, and symptom relief are vital for assessing chemotherapy effectiveness.
    • A balanced approach considering both quality and quantity of life is needed for patients with metastatic non-small cell lung cancer.